Can a newer heart failure drug protect kidneys better than an older one?
Disease control
Completed
This trial tests whether sacubitril/valsartan, a newer heart failure medication, is safer and more effective for the kidneys than ramipril, an older ACE inhibitor, in people hospitalized with acute decompensated heart failure who also have chronic kidney disease. About 515 partic…
Phase: PHASE2, PHASE3 • Sponsor: National Heart Institute, Egypt • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC